Helios Technologies (HLIO), MKS Instruments (MKSI), Henry Schein (HSIC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Helios Technologies (HLIO)
51.5% sales growth and 9.18% return on equity
Helios Technologies, Inc., together with its subsidiaries, develops, manufactures, and sells solutions for the hydraulics and electronics markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Helios Technologies's sales growth this year is anticipated to be 45.5% and 7.9% for next year.
Year-on-year quarterly revenue growth grew by 58.2%, now sitting on 598.4M for the twelve trailing months.
Volume
Today's last reported volume for Helios Technologies is 48278 which is 52.08% below its average volume of 100747.
Helios Technologies's sales growth for the next quarter is 51.5%. The company's growth estimates for the current quarter and the next is 56.4% and 56.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.18%.
Volatility
Helios Technologies's last day, last week, and last month's current volatility was 1.53%, 1.15%, and 1.63%, respectively.
Helios Technologies's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.74% (day), 2.30% (last week), and 3.03% (last month), respectively.
Helios Technologies's Stock Yearly Top and Bottom Value
Helios Technologies's stock is valued at $77.56 at 02:22 EST, under its 52-week high of $79.10 and way above its 52-week low of $31.56.
Helios Technologies's Moving Average
Helios Technologies's worth is higher than its 50-day moving average of $74.28 and way above its 200-day moving average of $67.21.2. MKS Instruments (MKSI)
30% sales growth and 17.84% return on equity
MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes worldwide.
MKS Instruments's sales growth this year is expected to be 24.5% and 7.1% for next year.
Year-on-year quarterly revenue growth grew by 29.5%, now sitting on 2.49B for the twelve trailing months.
Volume
Today's last reported volume for MKS Instruments is 207007 which is 36.62% below its average volume of 326603.
MKS Instruments's sales growth is a negative 0% for the ongoing quarter and 30% for the next. The company's growth estimates for the present quarter and the next is 81.5% and 40.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.84%.
Volatility
MKS Instruments's last day, last week, and last month's current volatility was 0.70%, 0.71%, and 1.97%, respectively.
MKS Instruments's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.71% (day), 2.37% (last week), and 3.46% (last month), respectively.
MKS Instruments's Stock Yearly Top and Bottom Value
MKS Instruments's stock is valued at $177.95 at 02:22 EST, way below its 52-week high of $199.44 and way above its 52-week low of $101.78.
MKS Instruments's Moving Average
MKS Instruments's worth is under its 50-day moving average of $179.03 and higher than its 200-day moving average of $172.60.Previous days news about MKS Instruments(MKSI)
According to CNBC on Thursday, 1 July, "Atotech (ATCThe specialty chemicals company agreed to be acquired by industrial solutions company MKS Instruments (MKSI) in a $5.1 billion cash-and-stock deal. "
3. Henry Schein (HSIC)
16.5% sales growth and 11.04% return on equity
Henry Schein, Inc., a solutions company for health care professionals, provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide.
Henry Schein's sales growth this year is expected to be 16% and 1.9% for next year.
Year-on-year quarterly revenue growth grew by 20.4%, now sitting on 10.62B for the twelve trailing months.
Volume
Today's last reported volume for Henry Schein is 729971 which is 20.05% below its average volume of 913039.
Henry Schein's sales growth for the next quarter is 16.5%. The company's growth estimates for the present quarter and the next is a negative 0% and negative -10.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.04%.
Volatility
Henry Schein's last day, last week, and last month's current volatility was 1.40%, 0.93%, and 1.63%, respectively.
Henry Schein's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.97% (day), 1.89% (last week), and 2.78% (last month), respectively.
Henry Schein's Stock Yearly Top and Bottom Value
Henry Schein's stock is valued at $75.97 at 02:22 EST, below its 52-week high of $83.45 and way above its 52-week low of $54.25.
Henry Schein's Moving Average
Henry Schein's worth is under its 50-day moving average of $76.86 and higher than its 200-day moving average of $71.29.4. ResMed (RMD)
11.6% sales growth and 18.42% return on equity
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases.
ResMed's sales growth this year is expected to be 5.2% and 8.9% for next year.
Year-on-year quarterly revenue growth declined by 0.1%, now sitting on 3.09B for the twelve trailing months.
Volume
Today's last reported volume for ResMed is 373313 which is 40.86% below its average volume of 631287.
ResMed's sales growth for the next quarter is 11.6%. The company's growth estimates for the ongoing quarter and the next is a negative 4.5% and negative -1.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.42%.
Volatility
ResMed's last day, last week, and last month's current volatility was 0.55%, 0.52%, and 1.25%, respectively.
ResMed's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.33% (day), 1.13% (last week), and 1.83% (last month), respectively.
ResMed's Stock Yearly Top and Bottom Value
ResMed's stock is valued at $250.53 at 02:22 EST, above its 52-week high of $248.45.
ResMed's Moving Average
ResMed's worth is way above its 50-day moving average of $217.65 and way above its 200-day moving average of $206.03.5. Reynolds Consumer Products (REYN)
8.3% sales growth and 27.28% return on equity
Reynolds Consumer Products Inc. produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.
Reynolds Consumer Products's sales growth this year is anticipated to be 6.6% and 2.7% for next year.
Year-on-year quarterly revenue growth grew by 3.7%, now sitting on 3.29B for the twelve trailing months.
Volume
Today's last reported volume for Reynolds Consumer Products is 241795 which is 54.05% below its average volume of 526174.
Reynolds Consumer Products's sales growth for the next quarter is 8.3%. The company's growth estimates for the ongoing quarter and the next is a negative 30.9% and negative -16.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 27.28%.
Volatility
Reynolds Consumer Products's last day, last week, and last month's current volatility was 0.10%, 0.58%, and 1.10%, respectively.
Reynolds Consumer Products's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.97% (day), 1.37% (last week), and 2.26% (last month), respectively.
Reynolds Consumer Products's Stock Yearly Top and Bottom Value
Reynolds Consumer Products's stock is valued at $30.31 at 02:22 EST, way under its 52-week high of $35.69 and way higher than its 52-week low of $27.27.